Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Buckner

Showing results (231-240 of 417) with videos related to

Pageof 42
Sort By:
Leukemia Research|January 1, 1985
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporineC Irle, H J Deeg, C D Buckner, et al.
Journal of Hematotherapy|June 11, 1998
Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yieldsC H Weaver, K Tauer, B Zhen, et al.
Cancer Chemotherapy Reports|September 1, 1974
Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinomaC D Buckner, R Briggs, R A Clift, et al.
Bone Marrow Transplantation|January 1, 1988
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantationJ E Sanders, C D Buckner, R A Clift, et al.
Experimental Hematology|March 1, 1976
Recovery from aplastic anemia following attempted marrow transplantationE D Thomas, R Storb, E R Giblett, et al.
The New England Journal of Medicine|April 17, 1975
Bone-marrow transplantation (first of two parts)E Thomas, R Storb, R A Clift, et al.
Transplantation|September 1, 1983
Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantationJ E Sanders, C D Buckner, J M Leonard, et al.
Blood|August 1, 1994
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.
Pharmacoeconomics|June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.
Blood|May 1, 1991
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.
Pageof 42

Showing results (231-240 of 417) with videos related to

Sort By:
Pageof 42
Leukemia Research|January 1, 1985
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporineC Irle, H J Deeg, C D Buckner, et al.
Journal of Hematotherapy|June 11, 1998
Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yieldsC H Weaver, K Tauer, B Zhen, et al.
Cancer Chemotherapy Reports|September 1, 1974
Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinomaC D Buckner, R Briggs, R A Clift, et al.
Bone Marrow Transplantation|January 1, 1988
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantationJ E Sanders, C D Buckner, R A Clift, et al.
Experimental Hematology|March 1, 1976
Recovery from aplastic anemia following attempted marrow transplantationE D Thomas, R Storb, E R Giblett, et al.
The New England Journal of Medicine|April 17, 1975
Bone-marrow transplantation (first of two parts)E Thomas, R Storb, R A Clift, et al.
Transplantation|September 1, 1983
Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantationJ E Sanders, C D Buckner, J M Leonard, et al.
Blood|August 1, 1994
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.
Pharmacoeconomics|June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.
Blood|May 1, 1991
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.
Pageof 42